-
Information-Publications
-
Injectable Bioactive Antioxidative One‐Component Polycitrate Hydrogel with Anti‐Inflammatory Effects for Osteoarthritis Alleviation and Cartilage ProtectionDetails
-
Long-read sequencing of 945 Han individuals identifies novel structural variants associated with phenotypic diversity and disease susceptibilityDetails
-
Low‑dose ionizing radiation attenuates high glucose‑induced hepatic apoptosis and immune factor release via modulation of a miR‑155‑SOCS1 axisDetails
-
Identification of potential hub genes associated with atopic dermatitis-like recombinant human epidermal model using integrated transcriptomic and proteomic …Details
-
Integrative analysis of DNA methylome and transcriptome reveals epigenetic regulation of bisphenols-induced cardiomyocyte hypertrophyDetails
-
VEGF‐C/VEGFR‐3 axis protects against pressure‐overload induced cardiac dysfunction through regulation of lymphangiogenesisDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands